Search

Your search keyword '"Graham, Irene"' showing total 149 results

Search Constraints

Start Over You searched for: Author "Graham, Irene" Remove constraint Author: "Graham, Irene"
149 results on '"Graham, Irene"'

Search Results

1. Risk of COVID-19 after natural infection or vaccination

2. Risk of COVID-19 after natural infection or vaccination

4. Tularemia vaccine: Safety, reactogenicity, “Take” skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain – A phase 2 randomized clinical Trial

5. Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial

7. Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

9. Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children

12. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

14. Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial

20. Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine With MF59 Adjuvant: A Randomized Clinical Trial

23. Integrin alpha(v)beta(3), differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha5beta1

24. Complement receptor 3 (CR3, Mac-1 integrin alpha(M)beta(2), CD11b/CD18) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils

25. Immune complex-stimulated neutrophil LTB4 production is dependent on beta-2 integrins

30. Purity postponed

31. Enhanced Potency and Durability of Antibody Response to Seasonal Trivalent Inactivated Influenza Vaccine (TIV) Combined with a Novel Water-in-Oil Adjuvant System at Reduced Hemagglutinin (HA) Doses

35. Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults

36. Who are the know-nothings?

39. Spam bill to slice up victims

40. Readers' Tips.

45. Letters to the Editors.

Catalog

Books, media, physical & digital resources